Nardi's Rib Cage Injury Forces Miami to Gamble on Rookie Bullpen Depth
By Erik Schwartz ·
The Marlins lose a left-handed reliever to a stress reaction just as their bullpen was stabilizing, opening the door for an unproven rookie with elite strikeout stuff but minimal MLB experience.
The Marlins placed left-handed reliever Andrew Nardi on the 15-day injured list Saturday with a left rib cage stress reaction, clearing roster space for rookie William Kempner's second recall of the season. The injury is retroactive to Thursday, removing depth from a bullpen already thin on reliable left-handed options as Miami prepares for league play ahead.
Nardi's timing is particularly costly. After a brutal 2025 missed entirely to back trouble and a shortened 2024 cut short by elbow strain, he finally pieced together a full season's worth of innings in 2026—22 2/3 frames across 25 appearances. His peripherals tell the story of a pitcher fighting to stay healthy: a 5.16 ERA masks a 1.41 WHIP and 10.7 K/9 rate that suggests he's been finding outs when his command cooperates. His last outing against Toronto exemplified the inconsistency—a season-high 1 1/3 innings in which he surrendered the decisive solo homer. The recurring soft-tissue issues that have defined his career now resurface at a moment when he appeared close to establishing durability.
What Miami loses in Nardi is the left-side platoon relief they desperately needed. The Marlins' other southpaw options—veteran John King (1.93 ERA, 26 appearances) and second-year Cade Gibson (8.59 ERA, five outings)—present a stark contrast. King is reliable; Gibson is a lottery ticket. King will likely absorb most of the high-leverage left-handed work, which compounds pressure on him and narrows Miami's bullpen flexibility. Kempner, the recalled rookie, offers intriguing stuff on his resumé (16.1 K/9 in Triple-A, five saves across 19 games) but only one career MLB appearance—a perfect inning on eight pitches against Baltimore on May 5. The step from dominant minor-league strikeout guy to functional big-league reliever is not automatic, particularly in tight spots.
For bettors, this creates a two-layer edge. First, Miami's bullpen efficiency metrics will likely soften over the next two weeks as King absorbs disproportionate volume and fatigue risk, making Marlins overs slightly more vulnerable if they're facing competent offenses (the Mets are not one, but upcoming matchups matter). Second, and more directly: Kempner's high strikeout rate (16.1 K/9 in the minors) is genuine, but the book has almost no real-world sample to price. If Kempner enters games against strikeout-prone lineups early in his tenure, his K prop could carry value on the unders side—not because he'll fail, but because bettors will initially price the 16.1 K/9 as a baseline without discounting for MLB adjustment variance. Once he appears in a handful of games, the market will normalize. That window is narrow.
The more durable angle: fade Miami bullpen props (ERA, WHIP) and lean overs on opponent team totals when facing the Marlins over the next 10 days. King's workload will spike; Kempner is high-risk; Gibson offers little comfort. Teams that can work counts and avoid the strikeout will find opportunities. This is a depth crisis masquerading as roster maintenance.